Cargando…
索拉非尼单药治疗FLT3-ITD突变阳性急性髓系白血病14例疗效及安全性分析
OBJECTIVE: To explore the efficacy and safety of Sorafenib as monotherapy to FLT3 positive acute myeloid leukemia (AML). METHODS: From April 2014 to December 2015, fourteen AML patients with FLT3 positive, 7 males and 7 females with a median age of 42 (range: 14–81) years old, were enrolled in this...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348496/ https://www.ncbi.nlm.nih.gov/pubmed/28088962 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.12.002 |